Global Reach Health

September 23, 2020
Global Reach Health

Updated Black Box Warning for Benzodiazepines

September 23, 2020 –The U.S. FDA is requiring an update to the black box warning – the agency’s most prominent safety warning on drug labels – for benzodiazepines. The warning describes
September 22, 2020
Global Reach Health

Perrigo Voluntarily Recalls Albuterol Inhalers

September 22, 2020 –Perrigo has voluntarily recalled all unexpired albuterol sulfate inhalation aerosol manufactured by Catalent Pharma Solutions for Perrigo. The recall is due to possible
September 17, 2020
Global Reach Health

Acella Recalls Two Lots of NP Thyroid

September 17, 2020 –Acella Pharmaceuticals has voluntarily recalled one lot of 15mg and one lot of 120mg NP Thyroid®, Thyroid Tablets, USP (levothyroxine and liothyronine) due
September 17, 2020
Global Reach Health

FDA Withdraws Approval for Belviq and Belviq XR

September 17, 2020 –The U.S. FDA has withdrawn approval for Belviq® (lorcaserin HCl) and Belviq XR® (lorcaserin HCl extended release), manufactured by Eisai. Both drugs were indicated
September 9, 2020
Global Reach Health

New Tramadol Oral Solution Approved

September 9, 2020 –The U.S. FDA has approved Qdolo® (tramadol) 5mg/mL oral solution, manufactured by Athena Biosciences. The drug is indicated to manage pain severe enough to require
September 9, 2020
Global Reach Health

Trelegy Ellipta Receives New Asthma Indication

September 9, 2020 –The U.S. FDA has approved a new indication for Trelegy® ElliptaTM (fluticasone furoate/umeclidinium/vilanterol) oral inhalation powder, manufactured by GlaxoSmithKline
September 7, 2020
Global-reach-rx-drug-news

Gavreto Approved to Treat Lung Cancer

September 7, 2020 –The U.S. FDA has approved GavretoTM (pralsetinib), manufactured by Roche, to treat adults diagnosed with metastatic rearranged-during-transfection (RET) fusion-positive